Malignant focal liver lesions displaying rim arterial phase hyperenhancement may have a vascular, hepatocellular, biliary, lymphoid, or secondary origin. The differences in imaging characteristics on contrast-enhanced CT may be subtle, and a multiparametric approach on MRI may be helpful to narrow the...
18 Recently, a randomised, international phase 3 trial (CARES-310) suggested that camrelizumab plus rivoceranib showed a statistically significant and clinically meaningful benefit in progression-free survival (PFS) and overall survival (OS) compared with sorafenib for patients with uHCC.19 These ...
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Lancet Oncol. 2020;21(6):808–820. doi:10.1016/S1470-2045(20)30156-X 41. Tsuchiya K, Kurosaki M, Marusawa H, et al. The efficacy and safety of ...
This prospective, open-label, single-arm phase II study was conducted at the First Affiliated Hospital of Zhejiang University School of Medicine in February 2022 to investigate the efficacy and safety of envafolimab plus lenvatinib and TACE in intermediate to advanced uHCC. Eligible patients with ...
Objective To explore the diagnostic value of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid(Gd-EOB-DTPA)-enhanced MRI in recurrent small lesions of primary liver cancer after transcatheter arterial chemoembolization(TACE).Method A total of 52 patients with primary liver cancer treated in our ...
To investigate a benefit from virtual monoenergetic reconstructions (VMIs) for assessment of arterially hyper-enhancing liver lesions in phantom and patients and to compare hybrid-iterative and spectral image reconstructions of conventional images (CI-IR and CI-SR). Methods All imaging was performed ...
Triple phase arterial contrast enhanced MRI for the detection of liver lesions – initial experience - ScienceDirectdoi:10.1016/j.crad.2019.09.127RachelAllardDanielWilsonRaneemAlbazazClaireSmithMariaSheridanClinical Radiology
“Nondefect” of Arterial Enhancing Rim on Hepatobiliary Phase in 3.0-T Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid–Enhanced Liver Magnetic Resonance Imaging: Distinguishing Hepatic Abscess from Metastasis[J] . Seung Hee Choi,Chang Hee Lee,Baek Hui Kim,Jongmee Lee,Jae Woong Choi,Yang ...
Sun HY, Lee JM, Shin CI et al (2010) Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging. Invest Radiol 45:96–103 Article PubMed CAS...
[169]. Therefore, EP4 is a potential therapeutic target for improving pulmonary vascular remodeling and enhancing RV function of lower IP expression related to PAH. The beneficial effects of another PGI2analog, beraprost (BPS), on vascular contraction in PH may be mediated, partly through ...